A	B	C	D	E	F	G	H	I	J	K	L
1
2		Brand	MOA	Indication	Phase					Price	23.75
3		ZN-c3	Wee1	Solid Tumors, uterine serous carcinoma	II					Shares	57.069491	Q322
4		ZN-d5	BCL-2	NHL						MC	1355.40041125
5			BCL-xL							Cash	449.761	Q322
6										Debt	0	Q322
7										EV	905.63941125
8
9
10
11						Discontinued ZN-c5 (SERD), ZN-e4 (EGFR)